ATM-AVI + Metronidazole
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Complicated Intra-Abdominal Infections, cIAIs
Conditions
Complicated Intra-Abdominal Infections, cIAIs
Trial Timeline
May 19, 2016 → Oct 26, 2017
NCT ID
NCT02655419About ATM-AVI + Metronidazole
ATM-AVI + Metronidazole is a phase 2 stage product being developed by Pfizer for Complicated Intra-Abdominal Infections, cIAIs. The current trial status is completed. This product is registered under clinical trial identifier NCT02655419. Target conditions include Complicated Intra-Abdominal Infections, cIAIs.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02655419 | Phase 2 | Completed |
Competing Products
20 competing products in Complicated Intra-Abdominal Infections, cIAIs